FGF19 and hepatocellular carcinoma: FGF401 induces tumor regression in high FGF19-expressing HCC models by modulating FGF19/FGFR-4 signaling, inhibiting proliferation, inducing apoptosis, and inhibiting hypoxia via blood vessel normalization, and this effect was further enhanced by the addition of vinorelbine.